Aprotinin in therapeutic doses inhibits chromogenic peptide substrate assays for protein C.
Wendel
H P
HP
Department of Thoracic and Cardiovascular Surgery, University of Tübingen, Germany.
Heller
W
W
Gallimore
M J
MJ
D007611:Aprotinin / Q000494:pharmacology* / Q000627:therapeutic use; D001681:Biological Assay; D002315:Cardiopulmonary Bypass; D002863:Chromogenic Compounds; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D010455:Peptides / Q000032:analysis*; D011486:Protein C / Q000037:antagonists & inhibitors*; D011897:Random Allocation
D002863:Chromogenic Compounds; D010455:Peptides; D011486:Protein C; D007611:Aprotinin